Page last updated: 2024-10-31

moxisylyte and Aging

moxisylyte has been researched along with Aging in 2 studies

Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)

Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.

Research Excerpts

ExcerptRelevanceReference
"In aging eyes phenylephrine drops have no significant effect on the depth of the anterior chamber, whereas pilocarpine drops produce a significant shallowing."3.66Acute shallowing of the anterior chamber. ( Mapstone, R, 1981)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mapstone, R1
Buckley, C1
Curtin, DM1
Docherty, J1
Eustace, P1

Other Studies

2 other studies available for moxisylyte and Aging

ArticleYear
Acute shallowing of the anterior chamber.
    The British journal of ophthalmology, 1981, Volume: 65, Issue:7

    Topics: Acetazolamide; Aged; Aging; Anterior Chamber; Glaucoma; Humans; Intraocular Pressure; Iris; Middle A

1981
Ageing and alpha 1 adrenoceptors in the iris.
    Eye (London, England), 1987, Volume: 1 ( Pt 2)

    Topics: Adult; Aged; Aged, 80 and over; Aging; Dose-Response Relationship, Drug; Humans; Iris; Moxisylyte; P

1987